Fibromodulin Gene Variants (FMOD) as Potential Biomarkers for Prostate Cancer and Benign Prostatic Hyperplasia

Table 1

Comparative analysis of quantitative variables between sample groups.

Variables	Control		BPH		PCa
		Values		Values		Values
Age (years)	82		90		44		<0.01	<0.05	<0.05	>0.05
BMI (kg)	75		84		24		0.509	>0.05	>0.05	>0.05
PSAT (ng/mL)	82		90		44		<0.01	—	—	—
PSAF (ng/mL)	82		90		44		<0.01	—	—	—
Prostate weight (g)	21		52		20		0.947	<0.05	<0.05	>0.05

Note: values indicate ; is the probabilistic value used to measure the significance of differences between the means of variables. is the probabilistic value used to measure the significance of differences between the control and BPH groups. is the probabilistic value used to measure the significance of differences between the control and PCa groups. is the probabilistic value used to measure the significance of differences between the BPH and PCa groups. Some variables were not passed on in part of the studied group. PSA_T: total prostate specific antigen; PSA_F: free prostate specific antigen; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; source: elaborated by the author.